Kodiak Sciences Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-230.0M | $-176.2M | $-260.5M | $-333.8M | $-267.0M | $-133.1M | $-47.4M | $-41.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $18.3M | $18.7M | $18.3M | $3.8M | $1.0M | $477.0K | $538.0K | $490.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $58.9M | $60.2M | $88.6M | $106.0M | $61.4M | $30.7M | $6.1M | $2.7M |
| Net Cash from Operating Activities | $-136.0M | $-117.3M | $-154.2M | $-206.5M | $-182.3M | $-83.4M | $-39.1M | $-29.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $506.0K | $375.0K | $41.4M | $37.0M | $17.0M | $3.8M | $437.0K | $78.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-506.0K | $-755.0K | $249.2M | $-336.5M | $-38.8M | $104.8M | $-137.0M | $-581.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | $0 |
| Net Cash from Financing Activities | $178.3M | $501.0K | $31.0K | $1.9M | $8.2M | $717.4M | $299.7M | $116.5M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-136.5M | $-117.7M | $-195.5M | $-243.5M | $-199.3M | $-87.2M | $-39.6M | $-29.1M |